The role of whole blood in thrombin generation in contact with various titanium surfaces

Biomaterials

Volumn 28, Issue 6, 2007, Pages 966-974

  Thor, Andreas ^a,b   Rasmusson, Lars ^b   Wennerberg, Ann ^b   Thomsen, Peter ^b   Hirsch, Jan Michael ^a   Nilsson, Bo ^c   Hong, Jaan ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Coagulation; Complement; Dental implant; Hydroxyapatite; Platelet activation; Thrombogenicity

Indexed keywords

COAGULATION; DENTAL PROSTHESES; HYDROXYAPATITE; MEDICAL APPLICATIONS; PLASMAS; TITANIUM DIOXIDE;

COMPLEMENT; PLATELET ACTIVATION; THROMBOGENICITY;

BLOOD;

FLUORIDE; HEPARIN; HYDROXYAPATITE; TITANIUM;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; BLOOD COMPONENT; CONTACT ANGLE; HUMAN; INCUBATION TIME; MATERIALS TESTING; NORMAL HUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; THROMBOGENESIS; TOOTH IMPLANTATION; TOOTH PROSTHESIS;

BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; BLOOD PHYSIOLOGY; CELLS, CULTURED; HUMANS; MATERIALS TESTING; PLATELET ACTIVATION; SURFACE PROPERTIES; THROMBIN; TITANIUM;

EID: 33751323234     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.10.020     Document Type: Article

References (51)

1. Hong J., Andersson J., Ekdahl K.N., Elgue G., Axen N., Larsson R., et al. Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis. Thromb Haemost 82 1 (1999) 58-64
2. Hong J., Larsson A., Ekdahl K.N., Elgue G., Larsson R., and Nilsson B. Contact between a polymer and whole blood: sequence of events leading to thrombin generation. J Lab Clin Med 138 2 (2001) 139-145
3. Frost A., Jonsson K.B., Ridefelt P., Nilsson O., Ljunghall S., and Ljunggren O. Thrombin, but not bradykinin, stimulates proliferation in isolated human osteoblasts, via a mechanism not dependent on endogenous prostaglandin formation. Acta Orthop Scand 70 5 (1999) 497-503
4. Schliephake H. Bone growth factors in maxillofacial reconstruction. Int J Oral Maxillofac Surg 31 (2002) 469-484
5. Henry P.J. Oral implant restoration for enhanced oral function. Clin Exp Pharmacol Physiol 32 1-2 (2005) 123-127
6. Tolman D.E. Reconstructive procedures with endosseous implants in grafted bone: a review of the literature. Int J Oral Maxillofac Implants 10 3 (1995) 275-294
7. Hallman M., Sennerby L., and Lundgren S. A clinical and histologic evaluation of implant integration in the posterior maxilla after sinus floor augmentation with autogenous bone, bovine hydroxyapatite, or a 20:80 mixture. Int J Oral Maxillofac Implants 17 5 (2002) 635-643
8. Lundgren S., Andersson S., Gualini F., and Sennerby L. Bone reformation with sinus membrane elevation: a new surgical technique for maxillary sinus floor augmentation. Clin Implant Dent Relat Res 6 3 (2004) 165-173
9. Thor A., Wannfors K., Sennerby L., and Rasmusson L. Reconstruction of the severely resorbed maxilla with autogenous bone, platelet-rich plasma, and implants: 1-year results of a controlled prospective 5-year study. Clin Implant Dent Relat Res 7 4 (2005) 209-220
10. Monov G., Fuerst G., Tepper G., Watzak G., Zechner W., and Watzek G. The effect of platelet-rich plasma upon implant stability measured by resonance frequency analysis in the lower anterior mandibles. Clin Oral Implants Res 16 4 (2005) 461-465
11. Kassolis J.D., and Reynolds M.A. Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation. J Craniofac Surg 16 2 (2005) 280-287
12. Weibrich G., Hansen T., Kleis W., Buch R., and Hitzler W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 34 4 (2004) 665-671
13. Lee J.J., Rouhfar L., and Beirne O.R. Survival of hydroxyapatite-coated implants: a meta-analytic review. J Oral Maxillofac Surg 58 12 (2000) 1372-1379 [discussion 9-80]
14. Cooper L.F., Zhou Y., Takebe J., Guo J., Abron A., Holmen A., et al. Fluoride modification effects on osteoblast behavior and bone formation at TiO2 grit-blasted c.p. titanium endosseous implants. Biomaterials 27 6 (2006) 926-936
15. Davidson J.A., Mishra A.K., Kovacs P., and Poggie R.A. New surface-hardened, low-modulus, corrosion-resistant Ti-13Nb-13Zr alloy for total hip arthroplasty. Biomed Mater Eng 4 3 (1994) 231-243
16. Hong J., Nilsson Ekdahl K., Reynolds H., Larsson R., and Nilsson B. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. Biomaterials 20 7 (1999) 603-611
17. Sanchez J., Elgue G., Riesenfeld J., and Olsson P. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin. Thromb Res 89 1 (1998) 41-50
18. Nilsson Ekdahl K., Nilsson B., Pekna M., and Nilsson U.R. Generation of iC3 at the interface between blood and gas. Scand J Immunol 35 1 (1992) 85-91
19. Mollnes T.E., Lea T., Harboe M., and Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 22 2 (1985) 183-195
20. Hong J., Azens A., Ekdahl K.N., Granqvist C.G., and Nilsson B. Material-specific thrombin generation following contact between metal surfaces and whole blood. Biomaterials 26 12 (2005) 1397-1403
21. Ulevitch R.J., and Johnston A.R. In vitro studies of prekallikrein activation in rabbit blood: the participation of red blood cells. J Immunol 124 4 (1980) 2027-2033
22. Sanchez J, Elgue G, Larsson R, Nilsson B, Olsson P. Surface adsorbed fibrinogen and fibrin are potent activators of the intrinsic coagulation system. 2006, submitted.
23. Radziwon P., Boczkowska-Radziwon B., Schenk J.F., Wojtukiewicz M.Z., Kloczko J., Giedrojc J., et al. Platelet activation and its role in thrombin generation in platelet-induced thrombin generation time. Thromb Res 100 5 (2000) 419-426
24. Peyrou V., Lormeau J.C., Herault J.P., Gaich C., Pfliegger A.M., and Herbert J.M. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 81 3 (1999) 400-406
25. Iwata H., Kaibara M., Dohmae N., Takio K., Himeno R., and Kawakami S. Purification, identification, and characterization of elastase on erythrocyte membrane as factor IX-activating enzyme. Biochem Biophys Res Commun 316 1 (2004) 65-70
26. Kaibara M., Iwata H., Ujiie H., Himeno R., and Kaibara M. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes. Blood Coagul Fibrin 16 5 (2005) 355-363
27. Baglia F.A., Badellino K.O., Li C.Q., Lopez J.A., and Walsh P.N. Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 277 3 (2002) 1662-1668
28. Pagel C.N., de Niese M.R., Abraham L.A., Chinni C., Song S.J., Pike R.N., et al. Inhibition of osteoblast apoptosis by thrombin. Bone 33 4 (2003) 733-743
29. Bluteau G., Bourges X., Bilban M., Spaethe R., Daculsi G., and Guicheux J. The modulation of gene expression in osteoblasts by thrombin coated on biphasic calcium phosphate ceramic. Biomaterials 27 15 (2006) 2934-2943
30. Wang H., Li X., Tomin E., Doty S.B., Lane J.M., Carney D.H., et al. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis. J Orthop Res 23 3 (2005) 671-679
31. Rompen E.H., Biewer R., Vanheusden A., Zahedi S., and Nusgens B. The influence of cortical perforations and of space filling with peripheral blood on the kinetics of guided bone generation. A comparative histometric study in the rat. Clin Oral Implants Res 10 2 (1999) 85-94
32. Anitua E., Andia I., Ardanza B., Nurden P., and Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 1 (2004) 4-15
33. Gruber R., Varga F., Fischer M.B., and Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 13 5 (2002) 529-535
34. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13 5 (1998) 793-802
35. Giachelli C.M. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14 9 Suppl 4 (2003) S300-S304
36. Ellegaard B., Kolsen-Petersen J., and Baelum V. Implant therapy involving maxillary sinus lift in periodontally compromised patients. Clin Oral Implants Res 8 4 (1997) 305-315
37. Thor A, Sennerby L, Hirsch JM, Rasmusson L. Bone formation at the maxillary sinus floor following simultaneous elevation of the mucosal lining and implant installation without graft material- An evaluation of 20 patients treated with 44 Astra Tech implants. J Oral Maxillofac Surg, in press.
38. Palma V., Magro-Filho O., de Oliveira J., Lundgren S., Salata L., and Sennerby L. Bone reformation and implant integration following maxillary sinus membrane elevation: an experimental study in primates. Clin Implant Dent Relat Res 8 1 (2006) 1-14
39. Park J.Y., and Davies J.E. Red blood cell and platelet interactions with titanium implant surfaces. Clin Oral Implants Res 11 6 (2000) 530-539
40. Carr Jr. M.E., and Hardin C.L. Fibrin has larger pores when formed in the presence of erythrocytes. Am J Physiol 253 5 Pt 2 (1987) H1069-H1073
41. Yoshida E., Ohmura S., Sugiki M., Anai K., and Maruyama M. A novel function of extraerythrocytic hemoglobin: identification of globin as a stimulant of plasminogen activator biosynthesis in human fibroblasts. Thromb Haemost 86 6 (2001) 1521-1527
42. Di Stasio E., Nagaswami C., Weisel J.W., and Di Cera E. Cl regulates the structure of the fibrin clot. Biophys J 75 4 (1998) 1973-1979
43. Collet J.P., Park D., Lesty C., Soria J., Soria C., Montalescot G., et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20 5 (2000) 1354-1361
44. Cheng K., Weng W., Wang H., and Zhang S. In vitro behavior of osteoblast-like cells on fluoridated hydroxyapatite coatings. Biomaterials 26 32 (2005) 6288-6295
45. Abildgaard U. Acceleration of Fibrin Polymerization by Acetate and Other Low Molecular Ions. Scand J Clin Lab Invest 16 (1964) 521-530
46. Ellingsen J.E., Johansson C.B., Wennerberg A., and Holmen A. Improved retention and bone-to-implant contact with fluoride-modified titanium implants. Improved retention and bone-tolmplant contact with fluoride-modified titanium implants. Int J Oral Maxillofac Implants 19 5 (2004) 659-666
47. Steinberg A.D., Willey R., and Drummond J.L. In-vivo comparisons of clot formation on titanium and hydroxyapatite-coated titanium. J Periodontol 63 12 (1992) 990-994
48. Tsuchiya H., Macak J.M., Muller L., Kunze J., Muller F., Greil P., Virtanen S., and Schmuki P. Hydroxyapatite growth on anodic TiO(2) nanotubes. J Biomed Mater Res A 77 3 (2006) 534-541
49. Klein C.P., Patka P., Wolke J.G., de Blieck-Hogervorst J.M., and de Groot K. Long-term in vivo study of plasma-sprayed coatings on titanium alloys of tetracalcium phosphate, hydroxyapatite and alpha-tricalcium phosphate. Biomaterials 15 2 (1994) 146-150
50. Karabuda C., Sandalli P., Yalcin S., Steflik D.E., and Parr G.R. Histologic and histomorphometric comparison of immediately placed hydroxyapatite-coated and titanium plasma-sprayed implants: a pilot study in dogs. Int J Oral Maxillofac Implants 14 4 (1999) 510-515
51. Nilsson B., Larsson R., Hong J., Elgue G., Ekdahl K.N., Sahu A., et al. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 92 5 (1998) 1661-1667